Adverse events in diabetes drug trial.

Full Abstract

No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Pechlaner, Christoph (C);

Journal and publication information

Publication Type: Comment; Letter

Journal: Lancet (Lancet), published in England. (Language: eng)

Reference: 2009-Oct; vol 374 (issue 9696) : pp 1144; author reply 1144-5

Dates: Created 2009/10/05; Completed 2009/10/15;

PMID: 19801086, status: MEDLINE (last retrieval date: 10/15/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

CommentOn: Lancet. 2009 Jul 4;374(9683):39-47. (PMID: 19515413)

CommentOn: Lancet. 2009 Jul 4;374(9683):4-6. (PMID: 19515414)

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Data Interpretation, Statistical
Diabetes Mellitus, Type 2 - drug therapy
Glucagon-Like Peptide 1 - adverse effects; analogs & derivatives
Humans
Peptides - adverse effects

Associated Chemicals: Peptides (0) ; Venoms (0) ; liraglutide (0) ; exenatide (141732-76-5) ; Glucagon-Like Peptide 1 (89750-14-1)

These are the highest related articles currently in the database:

Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. 15 Nov 2005
Exenatide and rare adverse events. 29 Apr 2008
[Glucagon-like peptide 1 (GLP-1)] 19 Jun 2007
[New concepts in the treatment of type 2 diabetes] 29 Jun 2007
Exenatide: pancreatitis. Watch out for nausea and vomiting. 30 May 2008
Diabetic gastroparesis. 24 Jul 2007
Exenatide and rare adverse events. 29 Apr 2008
Incretin-based therapies in type 2 diabetes mellitus. 13 Jul 2008
Drug interactions. 10 Jan 2008
Exenatide-induced depression in a geriatric patient. 30 Mar 2008

See 100+ related articles.